B

Benitec Biopharma
D

BNTC

11.400
USD
-0.34
(-2.90%)
مغلق
حجم التداول
1,710
الربح لكل سهم
-2
العائد الربحي
-
P/E
-18
حجم السوق
267,346,815
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Benitec Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.